1147108-97-1

Basic information

• Product Name: N-[2-(methylsulfonyl)phenyl]-2-phenyl-1,3-thiazole-4-carboxamide
• Synonyms: N-[2-(methylsulfonyl)phenyl]-2-phenyl-1,3-thiazole-4-carboxamide
• CAS NO: 1147108-97-1
• Molecular Weight: 358.442
• Mol File: 1147108-97-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[2-(methylsulfonyl)phenyl]-2-phenyl-1,3-thiazole-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-(methylsulfonyl)phenyl]-2-phenyl-1,3-thiazole-4-carboxamide(1147108-97-1)
• EPA Substance Registry System: N-[2-(methylsulfonyl)phenyl]-2-phenyl-1,3-thiazole-4-carboxamide(1147108-97-1)

Safety Data

• Hazardous Substances Data: 1147108-97-1(Hazardous Substances Data)

Upstream product

• 36094-04-9 2-phenyl-1,3-thiazole-4-carboxylic acid chloride 
• 2987-49-7 2-(methanesulfonyl)aniline monohydrochloride 

Relevant articles and documents

AZOLECARBOXAMIDE COMPOUND OR SALT THEREOF

[Object] To provide a therapeutic and/or prophylactic agent for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, based on an excellent trkA receptor inhibitory action. [Means for Solution] A novel azolecarboxamide compound in which a thiazole ring or an oxazole ring is bonded to a benzene ring, a pyridine ring, a pyridazine ring, a thiophene ring, a pyrazole ring or a pyrrole ring through carboxamide, or a salt thereof is confirmed to have a potent trkA receptor inhibitory activity, and found to be capable of being used as a therapeutic and/or prophylactic agent which is excellent in efficacy and safety for urinary frequency, urinary urgency, and urinary incontinence associated with various lower urinary tract diseases including overactive bladder, various lower urinary tract diseases accompanied by lower urinary tract pain, such as interstitial cystitis, chronic prostatitis, and the like, and various diseases accompanied by pain, thereby completing the present invention.